Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463 -68-2

China Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2, Find details about China Sermaglutide, CAS 910463-68-2 from Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2

Model NO.
Sermaglutide
Product Name
Sermaglutide
CAS No.
910463-68-2
Molecular Formula
C17h18f3n3o3
Molecular Weight
4113.57754
Melting Point
N/a
Boiling Point
N/a
Trademark
SENWAYER
Transport Package
Foil Bag
Specification
2mg/vial, 10 vials per box
Origin
China
HS Code
2924199090
Model NO.
Sermaglutide
Product Name
Sermaglutide
CAS No.
910463-68-2
Molecular Formula
C17h18f3n3o3
Molecular Weight
4113.57754
Melting Point
N/a
Boiling Point
N/a
Trademark
SENWAYER
Transport Package
Foil Bag
Specification
2mg/vial, 10 vials per box
Origin
China
HS Code
2924199090

Pharmaceutical Grade Best Price Sermaglutide powder CAS 910463-68-2

Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2
Product nameSermaglutide
CAS number910463-68-2
Molecular formulaC187H291N45O59
Molecular weight4113.57754

Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2
AppearanceWhite powder
Purity99.0%
FunctionSemaglutide can reduces hunger, food craving and body fat.
DiscribeSemaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Semaglutide (USAN; trade name Ozempic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.



Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2










Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2Pharmaceutical Grade Best Price Sermaglutide Powder CAS 910463-68-2